Psyllium — not fiber in general — helps IBS, largest review in a decade finds

What the researchers did

If you have irritable bowel syndrome (IBS), you have almost certainly been told to “eat more fiber.” It is one of the most common pieces of advice given to people with the condition, and for years it has rested on a mixed and messy evidence base: some trials of fiber showed benefit, others showed nothing, and some people felt worse. A team led by King's College London, working with Monash University, decided to settle the question properly. They ran a systematic review and meta-analysis — that is, they searched the entire published literature up to April 9, 2026, using a pre-registered plan (PROSPERO CRD42024600758), identified all the randomized controlled trials testing fiber supplements in adults with IBS, and pooled the results statistically into a single, more powerful estimate.

The search turned up 30 randomized controlled trials involving 1,904 adults with IBS. A randomized controlled trial, or RCT, is the gold-standard design in which participants are randomly assigned to receive either the treatment being tested or a comparison (often a placebo — an inactive look-alike), so that differences in outcomes can be attributed to the treatment rather than to chance or expectation. Crucially, the researchers did not treat “fiber” as one thing. They separated the trials by fiber type — most notably soluble, gel-forming fibers like psyllium (the husk of a plantain seed that swells into a gel in water) versus insoluble fibers like wheat bran — so they could see whether the generic advice holds up or whether the type of fiber is what matters. The work was published in Gastroenterology, one of the leading journals in the field, in August 2026.

What they found

The headline result comes from the 16 trials (1,293 participants) that reported what researchers call clinical response — meaning the proportion of people whose symptoms improved enough to count as a meaningful clinical change, not just a small shift on a questionnaire. In those trials, 52% of people taking fiber improved, compared with 44% of those on control — a relative risk of 1.21 (95% CI 1.03–1.41, p=.02). In plain words: people randomized to fiber were about 21% more likely to respond than those who were not, and the statistical confidence interval excludes 1.0, meaning the result is unlikely to be a fluke. The heterogeneity statistic (I²=38%) indicates moderate variation between trials — some studies found more effect than others, but not so much that the pooled average becomes meaningless.

But the more interesting story sits underneath that headline. When the researchers broke the results down by fiber type, the overall effect was carried almost entirely by psyllium. For psyllium specifically, the relative risk of clinical response was 1.53 (95% CI 1.06–2.19) — meaning people taking psyllium were roughly half again more likely to improve than those on placebo. That is a substantially stronger effect than the fiber-average figure, and it is the number that matters for anyone deciding what actually to try.

The counterpart finding is just as important: wheat bran did not separate from placebo. The classic insoluble fiber — the roughage many people picture when they hear the word “fiber,” and the one baked into countless cereals and bran muffins — showed no reliable benefit over placebo in these trials. In other words, the pooled data suggest that the generic instruction to “eat more fiber” is not merely imprecise; for the most commonly recommended type of fiber, it may simply be wrong for IBS.

The authors' conclusion, in essence: fiber is not interchangeable. The soluble, gel-forming fiber psyllium has a real, measurable effect on IBS symptoms in the best available evidence, while insoluble wheat bran does not. The finding echoes something many people with IBS already suspect from experience — that fiber tips are guesswork, and that some of them backfire with bloating. Here, the guesswork has been replaced with a pooled answer from the largest synthesis of this question in a decade.

“The question is not how much fiber, but which fiber — and only psyllium earned the answer.”

Why this result matters

If you live with IBS, part of the quiet dread is that nothing works — that you will cycle through diets, supplements and well-meaning advice and end up exactly where you started, or worse, bloated by the very things you were told would help. This analysis speaks directly to that fear in two directions at once. It says: there is one cheap, food-aisle fiber with the strongest evidence base yet assembled that it measurably helps. And it says: the blanket instruction to pile on the bran was, according to this pooled data, not supported. Both halves are liberating. One gives you something with a real signal behind it; the other gives you permission to stop forcing down fiber that was never shown to work for your condition.

There is also something refreshingly ordinary about the answer. The lever here is not an exotic protocol, an elimination crusade or an expensive product — it is a spoonful of psyllium husk in a glass of water. When the highest-quality evidence in a decade points to something that simple, that is worth knowing precisely because it is so unglamorous.

What this study can't tell us

Every meta-analysis is only as good as the trials inside it, and this one pools 30 studies of varying sizes, durations and designs — the moderate I² of 38% for the main result reflects that variation. The psyllium finding comes from a subgroup of trials, which is inherently less robust than the primary pooled analysis; the authors' own primary endpoint was reached for fiber overall, but the psyllium-versus-bran split is where the interpretation gets more cautious. The abstract does not report how long the trials lasted, how symptoms were individually measured, or who funded each included study (no vendor funding was identified, but the record is silent beyond that). And nothing here tells you how any individual person will respond — some people tolerate psyllium well, others find any added fiber uncomfortable at first.

It is also worth being precise about what “response” means here: a clinical improvement as defined by the trials, not a cure. IBS is a chronic, relapsing condition, and this evidence speaks to symptom improvement, not to resolving the underlying condition. Anyone with diagnosed IBS who is considering changing their fiber intake — especially anyone with alarm symptoms or other diagnoses — should do that conversation with a clinician, not with an article.

What this means for your plate

The finding itself is the guidance: in this pooled evidence, the fiber that helped people with IBS was psyllium — the soluble, gel-forming husk taken in water — not fiber in general and not wheat bran, which failed to beat placebo. The study's own flip side is equally practical: if you have been dutifully eating bran because “fiber is fiber,” this evidence does not back that for IBS. Whether psyllium is right for you, and how to introduce it gently, is a conversation for a qualified clinician who knows your history.

If you take one sentence away, let it be this: the question is not “how much fiber,” but which fiber — and in this decade's best evidence, only psyllium earned the answer.

The film

Prefer to watch it? The short film version of this study is on YouTube.

Watch on YouTube →